atezolizumab,pembrolizumab
merck,roche
['immotion010', 'rcc,(-irccs),(-srcc),(-urcc)', 'atezo', 'kn564']
axel bex discusses immotion010, adjuvant atezo in rcc, with a 38mo fu. negative for dfs as well as for os (immature). why is this negative and not kn564? slightly different patient selection, but diff drug efficacy? #esmo22 
Enjoying oncology, without meaning to sound too cynical